FIGURE 2.

Subject photographs of treatment success and long‐term management of inflammatory lesions of rosacea with subantibiotic dose oral doxycycline 40 mg. Subject pictured is a 43 year‐old male with severe inflammatory rosacea at baseline (A), successfully treated with topical metronidazole 1% and subantibiotic dose oral doxycycline, and assessed to have an IGA score of 0 (clear) at the week 12 visit (B). The subject was then randomized to receive subantibiotic dose oral doxycycline for an additional 40 weeks of treatment. The subject completed the 40‐week long‐term management part without relapse and was assessed to have an IGA score of 1 (near clear) at the final study visit (C)